Financial Ratios

MAHAVIR ADVANCED REMEDIES LTD.

NSE : NABSE : 531689ISIN CODE : INE716N01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE150.650 (0 %)
PREV CLOSE ( ) 150.65
OPEN PRICE ( ) 150.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 150.65 (308270)
VOLUME 4004
TODAY'S LOW / HIGH ( )150.65 150.65
52 WK LOW / HIGH ( ) 150.65150.65
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)0.12-0.13-0.84-0.13-0.17
   CEPS(Rs)0.12-0.13-0.84-0.02-0.05
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)7.747.621.522.361.46
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-77.01-117.97-152.57-3.14-9.44
   EBIT Margin(%)134.12-111.82-152.57-19.63-32.73
   Pre Tax Margin(%)133.89-112.14-152.57-19.63-32.79
   PAT Margin (%)133.89-112.14-152.57-19.63-32.79
   Cash Profit Margin (%)133.89-112.14-152.57-3.14-9.51
Performance Ratios
   ROA(%)1.58-3.27-36.20-4.42-5.75
   ROE(%)1.58-3.32-43.46-6.57-11.46
   ROCE(%)1.58-3.28-39.33-6.24-11.44
   Asset Turnover(x)0.010.030.240.230.18
   Sales/Fixed Asset(x)0.470.36
   Working Capital/Sales(x)0.010.020.320.463.12
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.002.122.77
   Receivable days0.00284.86187.14166.20213.70
   Inventory Days0.000.000.000.000.00
   Payable days175.09
Valuation Parameters
   PER(x)1613.770.000.000.000.00
   PCE(x)1613.770.000.000.000.00
   Price/Book(x)25.280.000.000.000.00
   Yield(%)0.00
   EV/Net Sales(x)2155.8783.1217.9615.6019.50
   EV/Core EBITDA(x)1607.38-74.33-11.77-496.15-206.51
   EV/EBIT(x)1607.38-74.33-11.77-79.47-59.57
   EV/CE(x)25.201.315.253.603.42
   M Cap / Sales2160.710.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-24.66-34.30-13.5325.290.00
   Core EBITDA Growth(%)190.3651.85-4095.3058.260.00
   EBIT Growth(%)190.3651.85-571.9424.840.00
   PAT Growth(%)189.9651.71-571.9424.990.00
   EPS Growth(%)189.9684.03-571.9524.990.00
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)976.710.0011.207.791.39
   Quick Ratio(x)976.710.0011.207.791.39
   Interest Cover(x)578.18-358.37-498.23
   Total Debt/Mcap(x)0.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.